$ADVM Adverum Biotechnologies, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adverum Biotechnologies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Adverum Biotechnologies, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Adverum Biotechnologies, Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Bain Linda | Chief Financial Officer | 41,930 | 0 | Aug 25 2015 | |||
| Barone Samuel B. | SVP, Clinical Development | 172,335 | 0 | Feb 13 2017 | |||
| Blumenkranz Mark S. | Director | 531,322 | 0 | Feb 17 2016 | |||
| Braun Shirley | VP, Human Resources | 161,140 | 0 | Feb 17 2016 | |||
| Carter Eric G | Director | 48,000 | 0 | Jun 25 2020 | |||
| Chalberg Thomas W. | Chief Executive Officer | 258,988 | 0 | Jun 11 2015 | |||
| Cheng Jennifer C. | General Counsel | 118,863 | 0 | Feb 19 2019 | |||
| Cleveland Paul B | Director | 22,727 | 0 | Jun 15 2018 | |||
| Countouriotis Athena | SVP, Chief Medical Officer | 150,000 | 0 | Feb 20 2018 | |||
| Finer Mitchell H. | Director | 603,069 | 0 | Aug 02 2019 | |||
| Fischer Laurent | CEO and Director | 26,292 | 0 | Mar 24 2021 | |||
| Flynn James E | 10% Owner | 627,267 | 0 | Aug 05 2014 | |||
| Gasmi Mehdi | Director | 279,442 | 0 | May 14 2021 | |||
| Graham Dawn | Director | 20,000 | 0 | May 14 2021 | |||
| GUERIN JOHN PATRICK ET AL | Director | 150,000 | 0 | Jun 11 2015 | |||
| Hemrajani Rekha | Director | 0 | 0 | Jun 25 2020 | |||
| Hull Hans | Chief Executive Officer | 137,210 | 0 | Aug 25 2015 | |||
| Leung Thomas | Chief Financial Officer | 0 | 0 | Feb 21 2020 | |||
| Lupher, Jr. Mark L. | Director | 0 | 0 | May 14 2021 | |||
| Machado Clarence Patrick | Director | 88,182 | 0 | May 14 2021 | |||
| MCLAUGHLIN JOHN PETER | Director | 10,333 | 0 | Feb 17 2016 | |||
| MCLAUGHLIN JOHN PETER | Director | 13,280 | 0 | Aug 07 2014 | |||
| MCLAUGHLIN JOHN PETER | Director | 0 | 0 | Aug 01 2014 | |||
| Osborne Aaron | Chief Medical Officer | 0 | 0 | Feb 18 2021 | |||
| PATTERSON LEONE D | President and CFO | 98,017 | 0 | Feb 18 2021 | |||
| REGENERON PHARMACEUTICALS INC | 10% Owner | 1,809,098 | 0 | Aug 05 2014 | |||
| Rubio Roman G. | SVP, Translational Medicine | 165,650 | 0 | Feb 17 2016 | |||
| Russo Carlo | EVP and Chief Medical Officer | 0 | 0 | May 13 2016 | |||
| Salzman Amber | President and CEO | 891,766 | 0 | Feb 20 2018 | |||
| Schwartz Steven Daniel | Director | 398,991 | 0 | Jun 14 2017 | |||
| Scopa James Paul | Director | 53,334 | 0 | May 14 2021 | |||
| Soparkar Peter | Chief Legal Officer | 10,692 | 0 | Feb 18 2021 | |||
| Spivey Richard N. | Director | 70,804 | 0 | Aug 02 2019 | |||
| Swartzburg Michael | Principal Accounting Officer | 82,113 | 0 | Feb 17 2016 | |||
| Thedinga Angela | Chief Technology Officer | 0 | 0 | Feb 18 2021 | |||
| Tuckson Reed Vaughn | Director | 0 | 0 | Feb 23 2021 | |||
| Venrock Associates VI, L.P. | 10% Owner | 2,365,471 | 0 | Aug 07 2014 | |||
| Venrock Healthcare Capital Partners II, L.P. | 10% Owner | 2,365,471 | 0 | Aug 07 2014 | |||
| Wachter Paul | Director | 31,951 | 0 | Mar 02 2016 | |||
| Wachter Paul | Director | 49,081 | 0 | Jan 15 2015 | |||
| Whitcup Scott M | Director | 0 | 0 | May 14 2021 | |||
| Woiwode Thomas | Director | 18,822 | 0 | May 14 2021 | |||
| Zygtech, LLC | 10% Owner | 2,438,176 | 0 | Apr 15 2015 |